SCHEMBL6937539

SCHEMBL6937539

CC(C)CCC[C@@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216798 1.00
SCHEMBL196610 1.00
SCHEMBL16675422 0.93 LMNA (0.53)
SCHEMBL16675428 0.93 LMNA (0.53)
SCHEMBL195900 0.93 LMNA (0.53)
SCHEMBL8908272 0.91 LMNA (0.68)
SCHEMBL10868893 0.91 LMNA (0.46)
SCHEMBL31509461 0.91 LMNA (0.68)
SCHEMBL6476873 0.91 LMNA (0.68)
SCHEMBL4826374 0.91 LMNA (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PSOMAGEN, INC. (US) 2022-08-23 US claimed
US-20210128498-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE MACROGEN INC. (KR) 2021-05-06 US claimed
EP-3668494-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE Psomagen, Inc. (US) 2020-06-24 EP claimed
CN-111163761-A Targeted drugs related to trimethylamine and/or trimethylamine-N-oxide 普梭梅根公司 2020-05-15 CN claimed
WO-2019036507-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE uBiome, Inc. (US) 2019-02-21 WO claimed
US-20190050525-A1 RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES PSOMAGEN, INC. 2019-02-14 US claimed
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PSOMAGEN, INC. (US) 2022-08-23 US disclosed
US-20210128498-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE MACROGEN INC. (KR) 2021-05-06 US disclosed
EP-3668494-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE Psomagen, Inc. (US) 2020-06-24 EP disclosed
CN-111163761-A Targeted drugs related to trimethylamine and/or trimethylamine-N-oxide 普梭梅根公司 2020-05-15 CN disclosed
WO-2019036507-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE uBiome, Inc. (US) 2019-02-21 WO disclosed
US-20190050525-A1 RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES PSOMAGEN, INC. 2019-02-14 US disclosed
EP-2077271-A1 MACROLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2009-07-08 EP disclosed
EP-0893429-B1 Ferrielectric liquid crystal compound MITSUBISHI GAS CHEMICAL CO (JP) 2001-03-07 EP disclosed
US-6197389-B1 AROMATIC ESTER COMPOUNDS HIGH SPEED RESPONSE IN SPITE OF A SMALL SPONTANEOUS POLARIZATION, MITSUBISHI GAS CHEMICAL COMPANY INC (JP) 2001-03-06 US disclosed
US-6133469-A HIGH PERFORMANCE LIQUID CRYSTAL DISPLAY DEVICES HAVING LARGER DISPLAY CAPACITY MITSUBISHI GAS CHEMICAL COMPANY (JP) 2000-10-17 US disclosed
EP-0978504-A1 Anti-ferroelectric liquid crystal compound MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-02-09 EP disclosed
EP-0974636-A1 Ferrielectric liquid crystal compound MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-01-26 EP disclosed
US-5972243-A FOR USE IN AN ACTIVE MATRIX-TYPE LIQUID CRYSTAL DISPLAY DEVICE IN WHICH EACH PIXEL IS INDIVIDUALLY DRIVEN BY THIN FILM TRANSISTOR OR METAL INSULATOR METAL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-10-26 US disclosed
EP-0893429-A1 Ferrielectric liquid crystal compound MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-01-27 EP disclosed